Patent · US Active

Polypeptides for inhibiting complement activation

US10640540B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

GREENOVATION BIOTECH GMBH · DE

Inventors

Stefan Michelfelder · Denzlingen, DE
Karsten Häffner · Freiburg (Elbe), DE

Key dates

Filing date	Dec 23, 2016
Grant date	May 5, 2020
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a polypeptide comprising a C3 convertase effector domain, a C5 convertase effector domain and optionally a terminal complex inhibitory effector domain which is resistant to deregulation by physiologic FHR-Proteins and has a dimerization motif, and to its therapeutic use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.